These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16340185)

  • 21. Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS Investigators.
    Saver JL; Johnston KC; Homer D; Wityk R; Koroshetz W; Truskowski LL; Haley EC
    Stroke; 1999 Feb; 30(2):293-8. PubMed ID: 9933262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health care resource use after acute stroke in the Glycine Antagonist in Neuroprotection (GAIN) Americas trial.
    Rundek T; Nielsen K; Phillips S; Johnston KC; Hux M; Watson D;
    Stroke; 2004 Jun; 35(6):1368-74. PubMed ID: 15118182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.
    Davis SM; Donnan GA; Parsons MW; Levi C; Butcher KS; Peeters A; Barber PA; Bladin C; De Silva DA; Byrnes G; Chalk JB; Fink JN; Kimber TE; Schultz D; Hand PJ; Frayne J; Hankey G; Muir K; Gerraty R; Tress BM; Desmond PM;
    Lancet Neurol; 2008 Apr; 7(4):299-309. PubMed ID: 18296121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical diagnosis of lacunar stroke in the first 6 hours after symptom onset: analysis of data from the glycine antagonist in neuroprotection (GAIN) Americas trial.
    Phillips SJ; Dai D; Mitnitski A; Gubitz GJ; Johnston KC; Koroshetz WJ; Furie KL; Black S; Heiselman DE;
    Stroke; 2007 Oct; 38(10):2706-11. PubMed ID: 17717313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. NINDS; The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
    Stroke; 2000 Dec; 31(12):2912-9. PubMed ID: 11108748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
    Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
    Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infarct volume-based subgroup selection in acute ischemic stroke trials.
    Kufner A; Wouters A; Bracoud L; Laage R; Schneider A; Schäbitz WR; Hermier M; Thijs V; Fiebach JB;
    Stroke; 2015 May; 46(5):1368-70. PubMed ID: 25765724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How a sequential design would have affected the GAIN International Study of gavestinel in stroke.
    Bolland K; Weeks A; Whitehead J; Lees KR;
    Cerebrovasc Dis; 2004; 17(2-3):111-7. PubMed ID: 14707409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP).
    Thomalla G; Fiebach JB; Østergaard L; Pedraza S; Thijs V; Nighoghossian N; Roy P; Muir KW; Ebinger M; Cheng B; Galinovic I; Cho TH; Puig J; Boutitie F; Simonsen CZ; Endres M; Fiehler J; Gerloff C;
    Int J Stroke; 2014 Aug; 9(6):829-36. PubMed ID: 23490032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke Trial.
    England TJ; Bath PM; Sare GM; Geeganage C; Moulin T; O'Neill D; Woimant F; Christensen H; De Deyn P; Leys D; Ringelstein EB;
    Stroke; 2010 Dec; 41(12):2834-9. PubMed ID: 21030711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-Arterial Therapy and Post-Treatment Infarct Volumes: Insights From the ESCAPE Randomized Controlled Trial.
    Al-Ajlan FS; Goyal M; Demchuk AM; Minhas P; Sabiq F; Assis Z; Willinsky R; Montanera WJ; Rempel JL; Shuaib A; Thornton J; Williams D; Roy D; Poppe AY; Jovin TG; Sapkota BL; Baxter BW; Krings T; Silver FL; Frei DF; Fanale C; Tampieri D; Teitelbaum J; Lum C; Dowlatshahi D; Shankar JJ; Barber PA; Hill MD; Menon BK;
    Stroke; 2016 Mar; 47(3):777-81. PubMed ID: 26892284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neuroprotective activity of the glycine receptor antagonist GV150526: an in vivo study by magnetic resonance imaging.
    Reggiani A; Pietra C; Arban R; Marzola P; Guerrini U; Ziviani L; Boicelli A; Sbarbati A; Osculati F
    Eur J Pharmacol; 2001 May; 419(2-3):147-53. PubMed ID: 11426836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal magnetic resonance perfusion-weighted imaging in lacunar infarcts predicts a low risk of early deterioration.
    Poppe AY; Coutts SB; Kosior J; Hill MD; O'Reilly CM; Demchuk AM
    Cerebrovasc Dis; 2009; 28(2):151-6. PubMed ID: 19546542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do acute diffusion- and perfusion-weighted MRI lesions identify final infarct volume in ischemic stroke?
    Rivers CS; Wardlaw JM; Armitage PA; Bastin ME; Carpenter TK; Cvoro V; Hand PJ; Dennis MS
    Stroke; 2006 Jan; 37(1):98-104. PubMed ID: 16322499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infarct volume on apparent diffusion coefficient maps correlates with length of stay and outcome after middle cerebral artery stroke.
    Engelter ST; Provenzale J; Petrella JR; DeLong DM; Alberts MJ
    Cerebrovasc Dis; 2003; 15(3):188-91. PubMed ID: 12646778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early magnetic resonance imaging prediction of arterial recanalization and late infarct volume in acute carotid artery stroke.
    Hermier M; Nighoghossian N; Adeleine P; Berthezène Y; Derex L; Yilmaz H; Dugor JF; Dardel P; Cotton F; Philippeau F; Trouillas P; Froment JC
    J Cereb Blood Flow Metab; 2003 Feb; 23(2):240-8. PubMed ID: 12571455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poststroke neurological improvement within 7 days is associated with subsequent deterioration.
    Aslanyan S; Weir CJ; Johnston SC; Lees KR;
    Stroke; 2004 Sep; 35(9):2165-70. PubMed ID: 15243144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gavestinel produces no benefit for stroke patients, study finds.
    Clin Resour Manag; 2001 Nov; 2(11):173-5, 161. PubMed ID: 11727452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of baseline magnetic resonance imaging (MRI) apparent diffusion coefficient lesion volume on functional outcome in ischemic stroke.
    Ma L; Gao PY; Hu QM; Lin Y; Jing LN; Xue J; Chen ZJ; Wang YJ; Liu ML; Cai YF
    Neurol Res; 2011 Jun; 33(5):494-502. PubMed ID: 21669118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting final infarct size using acute and subacute multiparametric MRI measurements in patients with ischemic stroke.
    Lu M; Mitsias PD; Ewing JR; Soltanian-Zadeh H; Bagher-Ebadian H; Zhao Q; Oja-Tebbe N; Patel SC; Chopp M
    J Magn Reson Imaging; 2005 May; 21(5):495-502. PubMed ID: 15834917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.